Vitamin tablets Shelcal, antiacid Pan-D, paracetamol IP 500 mg, Type-2 diabetic drug Glimepiride, hypertension drug Telmisartan and antibiotics Cepodem as well as Clavam were of non-standard quality.
To lift the suspension, companies relying on data from Indian CRO Synchron Research Services must provide alternative data demonstrating bioequivalence.